Zoracopan clinical trials
Also written ALXN2080.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2022
How each study uses zoracopan is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- ALXN2080
- 3
Studies by the year they started
3 studies that test it; most in 2022 (1)
| Year | Studies |
|---|---|
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
Who runs them
Industry 3 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses zoracopan is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- A Study to Investigate the Potential Drug Interactions Between ALXN2080 and Rosuvastatin and Metformin in Healthy Adult ParticipantsCompletedPhase 1Alexion Pharmaceuticals, Inc.NCT06160414Written as ALXN2080
- A Study to Evaluate Potential Drug Interactions Between ALXN2080 and Itraconazole, Fluconazole & Carbamazepine in Healthy AdultsCompletedPhase 1Alexion Pharmaceuticals, Inc.NCT06173596Written as ALXN2080
- Safety and Tolerability, PK, and PD Study of Single and Multiple ALXN2080 Doses in Healthy ParticipantsCompletedPhase 1Alexion Pharmaceuticals, Inc.NCT05428696Written as ALXN2080
Codes
What other systems call zoracopan · ClinicalTrials.gg INT016428
- UNII (FDA) E7799Y8LXYZORACOPANOne source FDA
- NCI Thesaurus C207023ZoracopanOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | E7799Y8LXY | ZORACOPAN | One source FDA |
| NCI Thesaurus | C207023 | Zoracopan | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.